[Focus Stock] NanoEntek Hits Upper Limit for Second Day on Hopes for Bio-Robot Supply

NanoEntek hit the daily upper price limit for the second consecutive session from early trading on the 24th.

At around 9:14 a.m. that day on the Korea Exchange, NanoEntek was trading at 7,670 won, up 30.0% from the previous session. It reached the upper price limit for the second straight day following the previous day.

Market participants interpret the rally as being driven by heightened expectations for the first global supply of a next-generation bio-robot, which has boosted investor sentiment. NanoEntek announced the previous day that it is moving into full-fledged discussions on supplying its "EVE-HT A26 cell mass analysis automation robot" with five global pharmaceutical companies and cell therapy research institutes.

Earlier this month, NanoEntek participated in SLAS 2026, an international life sciences and technology exhibition, where it held partnering meetings and prototype demonstrations with about 30 global pharmaceutical companies, including AstraZeneca and Regeneron, and gene therapy developers. The company said it is currently in detailed talks with five of these top-tier global pharmaceutical firms regarding delivery schedules and specific terms.

The EVE-HT A26 is a next-generation bio-robot that serves as an all-in-one platform automating the entire process from cell preprocessing to counting and analysis. Without any researcher intervention, it can process 96 samples within 15 minutes.

This content was produced with the assistance of AI translation services.